contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


chordate-participates-in-feminvests-investor-conference-in-stockholm-on-october-8th

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Chordate Medical Holding is a medical technology company that has developed, patented and CE-marked a nerve-modulating treatment technique for chronic migraine and chronic nasal congestion (rhinitis), Kinetic Oscillation Stimulation (KOS). The company sells its products to treating clinics in selected European markets, Israel and Saudi Arabia, with the aim of increasing its presence in the global market.

Chordate Medical Holding

Chordate Medical non-executive Director and main owner Caroline Lundgren Brandberg will participate in Feminvest's investor conference "Fearless" in Stockholm on October 8th. She will take part...

<div class="mfn-preamble"><p><strong>Chordate Medical non-executive Director and main owner Caroline Lundgren Brandberg will participate in Feminvest's investor conference "Fearless" in Stockholm on October 8th. She will take part in a panel discussion on entrepreneurship within publicly traded companies and growth in the life science sector.</strong></p></div><div class="mfn-body"><p>“We participated in Fearless in Oslo earlier this year and received very positive response both on the Ozilia treatment method and the investment case itself. Feminvest represents a broad and strong network of investors with a particular focus on femtech and life science, where Chordate and Ozilia are a good fit given that migraine is a condition that primarily affects women,” says Caroline Lundgren Brandberg, board member of Chordate Medical.</p><p>Feminvest is an acceleration network for female ownership through education, as well as an investment operation. It is currently the largest platform for female investors and entrepreneurs in the Nordics, with nearly 47,000 subscribers. Feminvest also manages a network of 300 female angel investors.</p><p>“Over the past year, we have increased our efforts to raise awareness of the company and Ozilia both among potential investors and in segments surrounding Life Science. Feminvest covers both of these groups, making it a particularly suitable forum for us,” says Anders Weilandt, CEO of Chordate.</p><p>Caroline Lundgren Brandberg, MSc. in Engineering Physics, eMBA, has been a board member of Chordate Medical since 2021. Caroline is the Global Sales Director at climate-tech company Deedster and has previously worked internationally for Ericsson in various senior roles focusing on sales and marketing. She also holds several board and advisory board positions, including at Stockholm University.<br><br><strong>Fearless Stockholm 2024 October Edition</strong><strong><br></strong>October 8th, 2024<br>Musikaliska Kvarteret, Nybrokajen 11, Stockholm<br>Read more: <a rel="noopener" href="https://feminvest.se/en/event/fearless-stockholm/">https://feminvest.se/en/event/fearless-stockholm/</a></p></div><div class="mfn-footer mfn-contacts mfn-69b71597c32e"><p><strong class="mfn-heading-1">For more information, please contact:</strong><br>Anders Weilandt, CEO<br><a rel="noopener" href="mailto:anders.weilandt@chordate.com">anders.weilandt@chordate.com</a><br>Cell: +46 733-874277</p></div><div class="mfn-footer mfn-about mfn-3b44868689f4"><p><strong class="mfn-heading-1">About Chordate</strong><br>Chordate Medical Holding AB (publ) is a medical technology company that has developed, patented and CE-marked Ozilia® Migraine, a neuromodulation and drug-free treatment technology for chronic migraine and chronic rhinitis. The treatment has clinically proven efficacy according to a recent study, and is marketed in selected markets in the EU and the Middle East. Chordate Medical is listed on Nasdaq First North Growth Market Stockholm (ticker: CMH). Read more at <a rel="noopener" href="https://www.chordate.com/en/">www.chordate.com</a></p><p>The company's Certified Adviser on Nasdaq First North Growth Market Stockholm is Vator Securities AB.<em><br></em><br><em>N.B. The English text is an in-house translation of the original Swedish text. Should there be any disparities between the Swedish and the English text, the Swedish text shall prevail.</em></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/875b2248-8022-4c8c-aa1c-d19a22cf028f/chordate-participates-in-feminvests-investor-conference-in-stockholm-on-october-8th.pdf" class="mfn-generated mfn-primary">Chordate participates in Feminvest's investor conference in Stockholm on October 8th</a></p></div>

Chordate participates in Feminvest's investor conference in Stockholm on October 8th

Tilmeld dig vores nyhedsbrev - ingen konto nødvendig!